Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Group
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.0856	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.1987	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.2122	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.2146	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.2349	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.2635	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.2680	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.2860	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.2867	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.3225	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.3540	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.3722	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.3786	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.3986	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.4245	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.4295	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.4468	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.4560	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.4775	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.4863	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.4888	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.5066	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.5783	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.5866	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.5893	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.5941	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.5971	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6133	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6256	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6418	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6561	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6606	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6607	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6684	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6725	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6770	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6860	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6894	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6946	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.6952	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7215	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7237	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7294	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7421	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7696	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7708	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7737	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7810	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7831	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7896	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.7909	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.8003	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.8276	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.8445	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.8498	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.8529	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.8596	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.8967	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.9218	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.9329	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.9377	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.9458	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.9624	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.9883	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	0.9900	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0000	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0165	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0213	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0253	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0406	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0508	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0538	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0715	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0787	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.0942	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1114	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1164	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1315	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1517	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1526	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1720	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1812	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1872	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1934	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.1972	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.2205	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.2399	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.2648	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.3490	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.3559	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.3628	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.3642	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.3943	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.4312	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.4417	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.4436	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.4601	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.4870	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.5403	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.5485	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.5721	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.5723	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.5860	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.6762	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.7660	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.7906	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.7917	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.8246	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.9076	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.9200	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.9508	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.9570	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.9835	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	1.9884	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.0298	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.0559	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.1001	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.1102	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.1180	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.1860	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.3361	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.3651	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.3835	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.4042	Peak area	Lean
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.5829	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.5907	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.7109	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	2.9599	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	3.0102	Peak area	Obese non neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	3.1755	Peak area	Obese neuropathy
Reversed phase POSITIVE ION MODE	phenylacetylglutamine	4.1635	Peak area	Obese neuropathy